Insights

Strategic investments Cure Ventures actively makes early stage investments in innovative biotech companies with a focus on de novo company formation around curative technologies, presenting a pipeline of potential portfolio companies to target for co-investment, partnerships, or advisory roles.

Recent portfolio activity Recent co-led and participated Series A investments in Tasca Therapeutics and Kenai Therapeutics indicate a readiness to deploy capital in biotech with large pharma validation, suggesting opportunities for follow-on rounds, strategic partnerships, or deal sourcing collaboration.

Clinical and IP focus The emphasis on genetic validation, mechanistic biology, robust IP positions, and expedited clinical routes signals opportunities to approach Cure Ventures with scientifically strong programs, licensing deals, or joint development opportunities that align with their thesis.

Scale and partnerships Cure Ventures seeks large market opportunities and string pharmaceutical partnerships, offering a path to enterprise collaborations, strategic licensing, or co-development arrangements with potential exit-oriented outcomes.

Operational footprint With a mid-sized team and a stated revenue range, Cure Ventures appears open to scalable, value-added partnerships beyond fund size, including advisory engagements, accelerator-style programs, or co-creation incubators that can accelerate portfolio company growth.

Cure Ventures Tech Stack

Cure Ventures uses 8 technology products and services including MySQL, Font Awesome, Google Fonts API, and more. Explore Cure Ventures's tech stack below.

  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • Slick
    Javascript Libraries
  • Piwik PRO Core
    Web Analytics
  • Ionicons
    Web Fonts
  • Apache
    Web Servers

Cure Ventures's Email Address Formats

Cure Ventures uses at least 1 format(s):
Cure Ventures Email FormatsExamplePercentage
FLast@curevc.comJDoe@curevc.com
91%
First.Last@curevc.comJohn.Doe@curevc.com
9%

Frequently Asked Questions

What is Cure Ventures's official website and social media links?

Minus sign iconPlus sign icon
Cure Ventures's official website is curevc.com and has social profiles on LinkedIn.

What is Cure Ventures's NAICS code?

Minus sign iconPlus sign icon
Cure Ventures's NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does Cure Ventures have currently?

Minus sign iconPlus sign icon
As of July 2026, Cure Ventures has approximately 18 employees across 1 continents, including North America. Key team members include Chief Technology Officer, Partner: B. A.Managing Partner And Co-Founder: L. T.Managing Partner And Co-Founder: R. L.. Explore Cure Ventures's employee directory with LeadIQ.

What industry does Cure Ventures belong to?

Minus sign iconPlus sign icon
Cure Ventures operates in the Venture Capital and Private Equity Principals industry.

What technology does Cure Ventures use?

Minus sign iconPlus sign icon
Cure Ventures's tech stack includes MySQLFont AwesomeGoogle Fonts APIJSON-LDSlickPiwik PRO CoreIoniconsApache.

What is Cure Ventures's email format?

Minus sign iconPlus sign icon
Cure Ventures's email format typically follows the pattern of FLast@curevc.com. Find more Cure Ventures email formats with LeadIQ.

When was Cure Ventures founded?

Minus sign iconPlus sign icon
Cure Ventures was founded in 2020.
Cure Ventures logo

Cure Ventures

Venture Capital and Private Equity PrincipalsMassachusetts, United States11-50 Employees

Cure Ventures is a venture capital and private equity firm based in Boston, Massachusetts, that concentrates on creating new companies around curative technologies. The firm emphasizes de novo company formation, developing ventures around bold ideas and scientists-entrepreneurs. It leverages its team's deep experience in building companies to tailor the amount and type of capital to each stage of a venture's life cycle. The focus is on disruptive scientific solutions with strong intellectual property, aiming to address unmet patient needs and pursue high-impact diseases.

In pursuing effective company builds, Cure Ventures looks for ventures with solid genetic validation and rigorously derived scientific data tied to a distinguished laboratory, clear mechanistic biology, and multiple commercial applications. It also prioritizes large, relatively untapped markets, streamlined clinical development pathways, and active partnership interest from large pharmaceutical companies, along with a defined path toward an exit.

Section iconCompany Overview

Website
curevc.com
NAICS Code
52391 - Miscellaneous Intermediation
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $10M$25M

    Cure Ventures's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Cure Ventures's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.